Analys

QLUCORE: Expanding pipeline of precision diagnostics projects

Analys, Research

With sales consisting of the data analytics software Omics Explorer, Qlucore reported revenue growth of 9% for the full year 2021/22...

Read More

BONZUN: A quarter of build-up for increased IVF action in H2

Analys

BONZUN The Q1’22 report showed some progress for Bonzun’s stress management service, Bonzun evolve, with an increased number of...

Read More

GRÄNGESBERG EXPLORATION: War and unfortunate geopolitical unrest clearly working in GRANGX’s favor

Analys, Research

With a structural long-term growth in demand for green CO2 free iron ore and a medium-term supply crisis following the risk of a cut off...

Read More

MOTION DISPLAY: Increased sales despite slow market return

Analys, Research

MOTION DISPLAY Sales in Q1 was MSEK 6.1, in line with our estimate of MSEK 6. While peers battle supply chain disruptions and fail their...

Read More

SWEDISH STIRLING: Initiating ramp-up with innovative financing structure to unlock value in pipeline

Analys, Research

SWEDISH STIRLING After having completed the production line in Sibbhult, Swedish Stirling now projects delivery of six PWR BLOKs to...

Read More

QLUCORE: Continued sector progression during market downturn

Analys, Research

QLUCORE Despite the pressure seen on the tech and life science sectors in the past six months, we note there is still progression in the...

Read More

Mushrooming opportunities with NLAW redraws the case in KebNi

Analys

KebNi’s report for Q1 2022 showed revenues largely in line with our estimate (6.2 vs 6.9 MSEK), driven by the postponed deliveries to...

Read More

Simris Alg fueling up for incoming CEO to build on accelerating momentum

Analys

On the back of 7.5 MSEK in orders in the last eight months and new CEO Julian Read taking the helm on May 16th, Simris is set to strengthen...

Read More

Agtira + Picadeli = sant

Analys

Det händer mycket på marknaden för vertikalodling och urban farming just nu, och trenden har vuxit sig allt starkare även i Sverige....

Read More

Start av Nanexas produktionsanläggning och klinisk studie av NEX-20 fokus 2022

Analys

Med en plan framåt för NEX-18 och nya produktionsanläggningen snart i drift ser vi ljust på chanserna för ett avtal om...

Read More

For new research on growth stocks, sign up to our newsletter